NCT05962788View on ClinicalTrials.gov

Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis

PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 27, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

June 30, 2029

Conditions
Adolescent Lupus NephritisPediatric Lupus Nephritis
Interventions
DRUG

voclosporin

Subjects will receive 2 capsules (15.8 mg) BID (twice daily), 3 capsules (23.7 mg) BID of voclosporin in addition to standard of care with mycophenolate mofetil (MMF) and steroids.

Trial Locations (6)

10700

Siriraj Hospital, Bangkok

27514

UNC-Chapel Hill, Chapel Hill

76100

Clinica de la Costa S.A.S, Barranquilla

97000

Centro de Especialidades Medicas del Sureste, Mérida

Unknown

Yokohama City University Hospital, Yokohama

06720

Hospital Infantil de México Federico Gómez, Mexico City

Sponsors
All Listed Sponsors
lead

Aurinia Pharmaceuticals Inc.

INDUSTRY